Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Learn about implementing the latest CDC pneumococcal vaccination recommendation for all eligible adults aged 50+ and aged 19-49 with certain underlying medical conditions,* addressing the unmet need for protection against pneumococcal disease in adults at increased risk, and the role of healthcare providers in improving adult pneumococcal vaccination rates.
(Note that the webinar cannot be viewed on a mobile device, please use a computer or tablet.)
Events
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Wednesday,
April 09, 2025
12:00–12:45 pm PT
Speaker
Arthur Jeng, MD
Professor of Clinical Medicine
David Geffen UCLA School of Medicine
Division of Infectious Diseases
Olive View-UCLA Medical Center
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Wednesday,
April 09, 2025
6:00–6:45 pm PT
Speaker
Arthur Jeng, MD
Professor of Clinical Medicine
David Geffen UCLA School of Medicine
Division of Infectious Diseases
Olive View-UCLA Medical Center
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Thursday,
April 10, 2025
12:00–12:45 pm MT
Speaker
Ruth M. Carrico, PhD, DNP, APRN, FNP-C, CIC, FSHEA, FNAP, FAAN
Carrico & Ramirez, PLLC
Professor (adjunct faculty)
Division of Infectious Diseases
University of Louisville School of Medicine
Louisville, KY
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Tuesday,
April 15, 2025
12:00–12:45 pm CT
Speaker
Lance Sloan, MD
President, Texas Institute for Kidney
and Endocrine Disorders
Lufkin, TX
Clinical Assistant Professor
University of Texas Medical Branch
Galveston, TX
Sam Houston State University
College of Osteopathic Medicine
Conroe, TX
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Thursday,
April 17, 2025
12:00–12:45 pm ET
Speaker
Yoav Golan, MD, MS, FIDSA
Senior Advisor
Clinical and Translational Research Center
Associate Professor
Tufts University School of Medicine
Boston, MA
Pneumococcal Vaccination in Adults:
Implementing the Latest CDC Recommendations
Thursday,
April 17, 2025
6:00–6:45 pm ET
Speaker
Yoav Golan, MD, MS, FIDSA
Senior Advisor
Clinical and Translational Research Center
Associate Professor
Tufts University School of Medicine
Boston, MA
*Alcoholism; chronic heart disease (including CHF and cardiomyopathies); chronic liver disease; chronic lung disease (including COPD, emphysema, and asthma); chronic renal failure¶; cigarette smoking; cochlear implant; congenital or acquired asplenia¶; cerebrospinal fluid leak; diabetes; generalized malignancy¶; HIV infection¶; Hodgkin disease¶; congenital or acquired immunodeficiency (includes B- [humoral] or T-lymphocyte deficiency, complement deficiencies [particularly C1, C2, C3, and C4 deficiencies], and phagocytic disorders [excluding chronic granulomatous disease])¶; iatrogenic immunosuppression (diseases requiring treatment with immunosuppressive drugs, including long-term systemic corticosteroids and radiation therapy)¶; leukemia¶; lymphoma¶; multiple myeloma¶; nephrotic syndrome¶; solid organ transplant¶; sickle cell disease or other hemoglobinopathies¶.
¶ Immunocompromising conditions.